1-4 of 4
Raymond P. Wu, Ph.D.
Close
Sort by
Journal Articles

Selective Inhibition of Activated B-Cell Lymphoma Cells by a Novel Small Molecule Inhibitor of NF-κB

John T, Norton, PhD, Tomoko Hayashi, M.D., Ph.D., Raymond P. Wu, Ph.D., Howard Cottam, PhD, Dennis A. Carson, M.D.
Journal: Blood
Blood (2011) 118 (21): 2498.
https://doi.org/10.1182/blood.V118.21.2498.2498
Published: 2011
Journal Articles

Increased Activity of Aldehyde Dehydrogenase, a Stem/Progenitor Cell Marker, in Chronic Lymphocytic Leukemia,

Raymond P. Wu, Ph.D., Christina C.N. Wu, Ph.D., Tomoko Hayashi, M.D., Ph.D., Laura Z. Rassenti, Ph.D., Thomas J. Kipps, M.D., Ph.D, Dennis A. Carson, M.D.
Journal: Blood
Blood (2011) 118 (21): 3867.
https://doi.org/10.1182/blood.V118.21.3867.3867
Published: 2011
Journal Articles

Agelastatin A (AgA), a Marine Sponge Derived Alkaloid, Inhibits Wnt/Beta-Catenin Signaling and Selectively Induces Apoptosis in Chronic Lymphocytic Leukemia Independently of p53

Michael Y. Choi, MD, Johanna Melo Cardenas, BSc, Desheng Lu, MD, PhD, Jian Yu, PhD, E. Paige Stout, PhD, Raymond P. Wu, Ph.D., John M Horton, B.S., Allison Gomez, Julio A. Diaz-Perez, M.D., M.S., Dennis A. Carson, M.D., Tadeusz F. Molinski, PhD, Thomas J. Kipps, M.D., Ph.D, Januario E. Castro, M.D.
Journal: Blood
Blood (2011) 118 (21): 1786.
https://doi.org/10.1182/blood.V118.21.1786.1786
Published: 2011
Journal Articles

Oxidative Stress Response and Cytotoxicity of Electrophilic Compounds in Primary Human Chronic Lymphocytic Leukemia.

Raymond P Wu, Ph.D., Tomoko Hayashi, M.D., Ph.D., Shiyin Yao, Christina C.N. Wu, Ph.D., Howard B Cottam, Ph.D., Michael Rosenbach, Richard B. Schwab, MD, Dennis A. Carson, MD
Journal: Blood
Blood (2009) 114 (22): 3444.
https://doi.org/10.1182/blood.V114.22.3444.3444
Published: 2009